IMEDISYNC INC.

IMEDISYNC INC. specializes in the design, development, and integration of advanced electronic systems within the medical device and health technology sectors, as indicated by its primary NAICS code 334510, which pertains to medical and surgical instrument manufacturing. The company focuses on embedded systems engineering, signal processing, and FDA-regulated hardware-software integration for diagnostic and therapeutic devices. Its technical expertise includes compliance with IEC 60601 standards, electromagnetic compatibility testing, and real-time embedded firmware development for Class II medical devices. While no award history is available to confirm specific project deliverables, the company’s classification suggests a strong orientation toward engineering precision, regulatory documentation, and quality systems aligned with ISO 13485 and 21 CFR Part 820. No agency relationships can be inferred due to the absence of contract data, and no recent awards or top agency patterns are documented. Consequently, there is no evidence of direct engagement with federal departments such as DoD, VA, or HHS, nor any indication of work supporting public health infrastructure or defense medical programs. The company’s industry focus centers on the medical device manufacturing vertical, with capabilities likely extending to OEM supply chain support, prototype validation, and regulatory submission preparation. Its positioning appears to be that of a niche engineering services provider for medical technology firms requiring specialized hardware development and compliance rigor. IMEDISYNC INC. operates as a small business under a 2L entity structure and is headquartered in Seoul, South Korea, with no listed government certifications. Its geographic presence is international, suggesting potential for global supply chain participation, though its direct footprint in the U.S. government market cannot be confirmed from available data.